Cash flow Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 11:12:46 05/12/2025 pm IST			After hours 02:03:47 am
5.454 ^EUR	-2.57%		5.472	+0.33%

04/12	Evotec's Partner Bayer Starts Mid-stage Study of Genetic Kidney Disease Drug	MT
04/12	Bayer Starts Phase IIa Study for Treatment of Patients with Alport Syndrome	CI

f53f37488a8faf0fbe485427d.2BBqZ-9_OS65kFAMkT03JpccdEblCm9Yt5NyCoeJTPo.k3k5HYdGYEKJowJH8lpxV9VuMneuaTkUjsMgerbKCcmBVFJQ2C1aFtX8FQ

Published financial data: EVOTEC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	50Cr	62Cr	75Cr	78Cr	80Cr
Total Revenues	50Cr	62Cr	75Cr	78Cr	80Cr
Cost of Goods Sold, Total	38Cr	47Cr	58Cr	61Cr	68Cr
Gross Profit	13Cr	15Cr	17Cr	18Cr	11Cr
Selling General & Admin Expenses, Total	7.68Cr	11Cr	16Cr	17Cr	19Cr
R&D Expenses	6.39Cr	7.22Cr	7.66Cr	6.85Cr	5.09Cr
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	-6.61Cr	-6.53Cr	-7.91Cr	-6.41Cr	-4.53Cr
Other Operating Expenses, Total	7.47Cr	11Cr	15Cr	17Cr	19Cr
Operating Income	5.1Cr	3.92Cr	2.03Cr	10.03L	-7.89Cr
Interest Expense, Total	-84.65L	-92.54L	-1.32Cr	-1.17Cr	-1.17Cr
Interest And Investment Income	29.09L	22.96L	83.36L	92.63L	24.35L
Net Interest Expenses	-55.56L	-69.58L	-48.14L	-24.76L	-92.64L
Income (Loss) On Equity Invest.	-1.04Cr	-1.66Cr	-1.6Cr	-2.08Cr	-43.12L
Currency Exchange Gains (Loss)	-69.35L	78.43L	1.31Cr	-25L	44L
Other Non Operating Income (Expenses)	3L	-61T	-7L	17.86L	-37.64L
EBT, Excl. Unusual Items	2.83Cr	2.35Cr	1.19Cr	-2.29Cr	-9.19Cr
Restructuring Charges	-	-	-	-	-5.49Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-43T	21Cr	-17Cr	-91.43L	-3.85Cr
Gain (Loss) On Sale Of Assets	-50T	-1L	-2L	-	-
Asset Writedown	-32.44L	-7L	-	-50.11L	-
Other Unusual Items	8L	26L	56.08L	-4.35Cr	-86.74L
EBT, Incl. Unusual Items	2.58Cr	24Cr	-15Cr	-8.06Cr	-19Cr
Income Tax Expense	1.96Cr	2.15Cr	2.17Cr	33.2L	21.02L
Earnings From Continuing Operations	62.52L	22Cr	-18Cr	-8.39Cr	-20Cr
Net Income to Company	62.52L	22Cr	-18Cr	-8.39Cr	-20Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	62.52L	22Cr	-18Cr	-8.39Cr	-20Cr
Net Income to Common Incl Extra Items	62.52L	22Cr	-18Cr	-8.39Cr	-20Cr
Net Income to Common Excl. Extra Items	62.52L	22Cr	-18Cr	-8.39Cr	-20Cr
Per Share Items
Net EPS - Basic	0.04	1.3	-0.99	-0.47	-1.11
Basic EPS - Continuing Operations	0.04	1.3	-0.99	-0.47	-1.11
Basic Weighted Average Shares Outstanding	15Cr	17Cr	18Cr	18Cr	18Cr
Net EPS - Diluted	0.04	1.3	-0.99	-0.47	-1.11
Diluted EPS - Continuing Operations	0.04	1.3	-0.99	-0.47	-1.11
Diluted Weighted Average Shares Outstanding	15Cr	17Cr	18Cr	18Cr	18Cr
Normalized Basic EPS	0.12	0.09	0.04	-0.08	-0.32
Normalized Diluted EPS	0.11	0.09	0.04	-0.08	-0.32
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	8.83Cr	8.93Cr	8.18Cr	7.21Cr	7L
EBITA	6.31Cr	4.96Cr	2.78Cr	71.27L	-7.3Cr
EBIT	5.1Cr	3.92Cr	2.03Cr	10.03L	-7.89Cr
EBITDAR	8.91Cr	9.02Cr	8.23Cr	7.24Cr	10L
Effective Tax Rate - (Ratio)	75.77	9.06	-14.09	-4.12	-1.08
Total Current Taxes	1.21Cr	1.64Cr	1.4Cr	79.17L	74.33L
Total Deferred Taxes	74.9L	50.66L	77.22L	-45.97L	-53.31L
Normalized Net Income	1.77Cr	1.47Cr	74.41L	-1.43Cr	-5.74Cr
Interest Capitalized	-	-	-	-	26.24L
Interest on Long-Term Debt	31.25L	37.28L	38.41L	58.32L	47.27L
Non-Cash Pension Expense	80T	98T	1L	-4L	-13.87L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	6.58Cr	7.35Cr	7.77Cr	7.39Cr	5.05Cr
Net Rental Expense, Total	8L	9L	5L	3L	3L
Imputed Operating Lease Interest Expense	1L	1L	1L	49.41T	73.12T
Imputed Operating Lease Depreciation	7L	8L	4L	2L	3L
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	52.85L	78.05L	99.19L	96.3L	50.35L
Total Stock-Based Compensation	52.85L	78.05L	99.19L	96.3L	50.35L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	42Cr	70Cr	42Cr	51Cr	31Cr
Short Term Investments	5.94Cr	16Cr	30Cr	9.32Cr	9.04Cr
Total Cash And Short Term Investments	48Cr	86Cr	72Cr	60Cr	40Cr
Accounts Receivable, Total	10Cr	15Cr	20Cr	12Cr	16Cr
Other Receivables	2.17Cr	2.34Cr	5.44Cr	8.07Cr	4.19Cr
Total Receivables	12Cr	18Cr	26Cr	20Cr	20Cr
Inventory	1.36Cr	2.58Cr	2.98Cr	3.09Cr	3.11Cr
Prepaid Expenses	92.58L	1.92Cr	1.69Cr	1.84Cr	2.22Cr
Other Current Assets, Total	3.18Cr	2.09Cr	5.17Cr	4.57Cr	2.76Cr
Total Current Assets	66Cr	110.09Cr	107.37Cr	90Cr	68Cr
Gross Property Plant And Equipment	48Cr	69Cr	92Cr	115.69Cr	130.16Cr
Accumulated Depreciation	-14Cr	-20Cr	-27Cr	-35Cr	-48Cr
Net Property Plant And Equipment	34Cr	48Cr	65Cr	81Cr	82Cr
Long-term Investments	5.9Cr	28Cr	15Cr	14Cr	4.22Cr
Goodwill	25Cr	26Cr	27Cr	28Cr	28Cr
Other Intangibles, Total	9.96Cr	3.09Cr	2.38Cr	1.55Cr	2.64Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	2.5Cr	1.74Cr	1.03Cr	1.43Cr	1.73Cr
Other Long-Term Assets, Total	3.74Cr	6.2Cr	7.73Cr	9.52Cr	3.78Cr
Total Assets	146.29Cr	223.52Cr	225.72Cr	225.25Cr	191.25Cr
Liabilities
Accounts Payable, Total	4.25Cr	7.26Cr	9.73Cr	13Cr	8.58Cr
Accrued Expenses, Total	3.6Cr	3.55Cr	4.92Cr	5.09Cr	4.63Cr
Short-term Borrowings	2L	-	-	-	-
Current Portion of Long-Term Debt	1.52Cr	3.61Cr	15.56L	13Cr	2.71Cr
Current Portion of Leases	1.46Cr	1.45Cr	1.48Cr	1.91Cr	1.96Cr
Current Income Taxes Payable	33.62L	1.06Cr	89.87L	55.65L	85.17L
Unearned Revenue Current, Total	7.06Cr	13Cr	14Cr	11Cr	11Cr
Other Current Liabilities	2.59Cr	2.85Cr	2.92Cr	1.69Cr	4.74Cr
Total Current Liabilities	21Cr	32Cr	34Cr	46Cr	34Cr
Long-Term Debt	33Cr	33Cr	33Cr	31Cr	26Cr
Long-Term Leases	13Cr	14Cr	16Cr	17Cr	13Cr
Unearned Revenue Non Current	2.61Cr	3.45Cr	21Cr	16Cr	19Cr
Pension & Other Post Retirement Benefits	1.53Cr	1.3Cr	1.25Cr	1.2Cr	1.02Cr
Deferred Tax Liability Non Current	2.04Cr	1.77Cr	1.85Cr	1.81Cr	1.45Cr
Other Non Current Liabilities	77.77L	55.38L	48.73L	54.65L	1.07Cr
Total Liabilities	74Cr	86Cr	107.01Cr	113.26Cr	96Cr
Common Stock, Total	16Cr	18Cr	18Cr	18Cr	18Cr
Additional Paid In Capital	103.07Cr	143.01Cr	144Cr	144.97Cr	145.47Cr
Retained Earnings	-43Cr	-22Cr	-39Cr	-48Cr	-67Cr
Comprehensive Income and Other	-3.75Cr	-1.26Cr	-3.74Cr	-3.06Cr	-73.46L
Total Common Equity	72Cr	137.77Cr	118.72Cr	111.99Cr	95Cr
Minority Interest	-	-	-	-	-
Total Equity	72Cr	137.77Cr	118.72Cr	111.99Cr	95Cr
Total Liabilities And Equity	146.29Cr	223.52Cr	225.72Cr	225.25Cr	191.25Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16Cr	18Cr	18Cr	18Cr	18Cr
ECS Total Common Shares Outstanding	16Cr	18Cr	18Cr	18Cr	18Cr
Book Value / Share	4.42	7.81	6.72	6.33	5.37
Tangible Book Value	38Cr	108.93Cr	89Cr	83Cr	64Cr
Tangible Book Value Per Share	2.3	6.18	5.03	4.68	3.63
Total Debt	49Cr	51Cr	51Cr	63Cr	44Cr
Net Debt	1Cr	-35Cr	-21Cr	2.21Cr	4.26Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	1.49Cr	1.22Cr
Debt Equivalent Oper. Leases	67.2L	71.6L	42.08L	23.84L	27.2L
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	3.97Cr	1.31Cr	1.6Cr	30.71L	21.38L
Account Code - Inventory Valuation	6	8	8	8	6
Inventories - Raw Materials, Total	1.33Cr	2.5Cr	2.79Cr	2.59Cr	2.95Cr
Inventories - Work In Process, Total	3L	8L	19.08L	49.89L	16.67L
Buildings, Total	5.66Cr	20Cr	24Cr	27Cr	32Cr
Machinery, Total	18Cr	26Cr	34Cr	40Cr	50Cr
Full Time Employees	3.57T	4.2T	4.95T	5.06T	4.74T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	8L	21L	28.33L	-	-
Order Backlog	45Cr	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	62.52L	22Cr	-18Cr	-8.39Cr	-20Cr
Depreciation & Amortization - CF	4.12Cr	5.56Cr	7.27Cr	8.6Cr	9.51Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.21Cr	1.03Cr	74.23L	61.24L	59.66L
Depreciation & Amortization, Total	5.33Cr	6.59Cr	8.01Cr	9.22Cr	10Cr
Amortization of Deferred Charges, Total - (CF)	27.27L	16.8L	15.59L	8L	5L
(Gain) Loss From Sale Of Asset	-1T	1L	2L	-	-
(Gain) Loss on Sale of Investments - (CF)	-15.27L	-22Cr	17Cr	91.43L	4.82Cr
Asset Writedown & Restructuring Costs	32.44L	7L	-	50.11L	1.22Cr
(Income) Loss On Equity Investments - (CF)	1.73Cr	2.84Cr	1.51Cr	2.08Cr	43.12L
Stock-Based Compensation (CF)	52.85L	78.05L	99.19L	96.3L	50.35L
Other Operating Activities, Total	-49.9L	2.8Cr	-1.95Cr	-72.19L	11Cr
Change In Accounts Receivable	-41.78L	-4.8Cr	-3.84Cr	-	-
Change In Inventories	-36.31L	-1.17Cr	-44.1L	-	-
Change In Accounts Payable	21.65L	3.13Cr	2.45Cr	-	-
Change in Unearned Revenues	-1.46Cr	6.31Cr	18Cr	-	-
Change In Income Taxes	1.55Cr	1.88Cr	2.94Cr	-	-
Change in Other Net Operating Assets	-3.21Cr	-5.59Cr	-7.36Cr	-99.44L	-6.82Cr
Cash from Operations	4.47Cr	12Cr	20Cr	3.64Cr	1.82Cr
Capital Expenditure	-9.91Cr	-12Cr	-18Cr	-21Cr	-12Cr
Sale of Property, Plant, and Equipment	-	-	-	5L	20L
Cash Acquisitions	-1.09Cr	-4L	-2.09Cr	20.88L	-
Sale (Purchase) of Intangible assets	-	-	-	-26.77L	-1.48Cr
Investment in Marketable and Equity Securities, Total	-3.88Cr	-12Cr	-21Cr	19Cr	4.91Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-62.42L	-73.76L	-41.27L	-	-
Other Investing Activities, Total	-	-	-	1.04Cr	99.87L
Cash from Investing	-16Cr	-24Cr	-42Cr	-1.33Cr	-7.12Cr
Long-Term Debt Issued, Total	2.15Cr	3.08Cr	-	22Cr	9L
Total Debt Issued	2.15Cr	3.08Cr	-	22Cr	9L
Long-Term Debt Repaid, Total	-2.67Cr	-3.67Cr	-5.31Cr	-14Cr	-15Cr
Total Debt Repaid	-2.67Cr	-3.67Cr	-5.31Cr	-14Cr	-15Cr
Issuance of Common Stock	25Cr	40Cr	7L	2L	4L
Other Financing Activities, Total	-	-	-	-1.29Cr	-97.16L
Cash from Financing	25Cr	40Cr	-5.24Cr	7.2Cr	-16Cr
Foreign Exchange Rate Adjustments	95.05L	-66T	-1.9Cr	6L	98.66L
Miscellaneous Cash Flow Adjustments	-	-	-	-1T	-
Net Change in Cash	15Cr	28Cr	-28Cr	9.58Cr	-20Cr
Supplemental Items
Cash Interest Paid	34.65L	54.29L	97.98L	1.29Cr	59.2L
Cash Income Tax Paid (Refund)	97.96L	-60.28L	1.85Cr	1.29Cr	-7.61Cr
Levered Free Cash Flow	-1.83Cr	48.66L	-15Cr	-6.98Cr	-8.59Cr
Unlevered Free Cash Flow	-1.3Cr	1.07Cr	-14Cr	-6.25Cr	-7.86Cr
Change In Net Working Capital	71.79L	-2.97Cr	6.51Cr	-5.03Cr	36.93L
Net Debt Issued / Repaid	-51.55L	-58.92L	-5.31Cr	8.46Cr	-15Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.41	1.33	0.57	0.03	-2.37
Return on Total Capital	2.96	1.58	0.71	0.04	-3.14
Return On Equity %	1.04	20.5	-13.7	-7.27	-18.92
Return on Common Equity	1.04	20.5	-13.7	-7.27	-18.92
Margin Analysis
Gross Profit Margin %	25.1	24.52	23.16	22.4	14.41
SG&A Margin	15.34	17.06	20.79	21.71	23.61
EBITDA Margin %	17.63	14.45	10.88	9.22	0.08
EBITA Margin %	12.6	8.02	3.69	0.91	-9.15
EBIT Margin %	10.18	6.35	2.71	0.13	-9.9
Income From Continuing Operations Margin %	1.25	34.87	-23.38	-10.74	-24.6
Net Income Margin %	1.25	34.87	-23.38	-10.74	-24.6
Net Avail. For Common Margin %	1.25	34.87	-23.38	-10.74	-24.6
Normalized Net Income Margin	3.54	2.37	0.99	-1.83	-7.2
Levered Free Cash Flow Margin	-3.66	0.79	-20.01	-8.93	-10.78
Unlevered Free Cash Flow Margin	-2.6	1.72	-18.91	-7.99	-9.86
Asset Turnover
Asset Turnover	0.38	0.33	0.33	0.35	0.38
Fixed Assets Turnover	1.75	1.5	1.32	1.07	0.98
Receivables Turnover (Average Receivables)	5.12	4.87	4.23	4.8	5.58
Inventory Turnover (Average Inventory)	30.84	23.69	20.76	19.97	22
Short Term Liquidity
Current Ratio	3.16	3.39	3.18	1.94	1.98
Quick Ratio	2.9	3.19	2.89	1.74	1.74
Operating Cash Flow to Current Liabilities	0.21	0.38	0.6	0.08	0.05
Days Sales Outstanding (Average Receivables)	71.45	74.96	86.37	76.07	65.61
Days Outstanding Inventory (Average Inventory)	11.87	15.41	17.58	18.27	16.64
Average Days Payable Outstanding	35.76	43.9	53.32	69.58	59.03
Cash Conversion Cycle (Average Days)	47.56	46.46	50.63	24.76	23.22
Long Term Solvency
Total Debt/Equity	68.06	37.23	42.68	55.92	46.13
Total Debt / Total Capital	40.5	27.13	29.91	35.86	31.57
LT Debt/Equity	63.91	33.56	41.3	42.6	41.23
Long-Term Debt / Total Capital	38.03	24.45	28.95	27.32	28.22
Total Liabilities / Total Assets	50.59	38.36	47.41	50.28	50.19
EBIT / Interest Expense	6.03	4.24	1.55	0.09	-6.75
EBITDA / Interest Expense	12.33	11.36	7.64	7.94	1.9
(EBITDA - Capex) / Interest Expense	0.62	-1.49	-6.15	-10.24	-8.14
Total Debt / EBITDA	4.71	4.88	5.05	6.72	19.81
Net Debt / EBITDA	0.1	-3.28	-2.11	0.24	1.92
Total Debt / (EBITDA - Capex)	93.35	-37.2	-6.26	-5.21	-4.61
Net Debt / (EBITDA - Capex)	1.9	25.04	2.62	-0.18	-0.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.2	23.38	21.59	3.99	1.99
Gross Profit, 1 Yr. Growth %	-5.38	20.52	14.86	0.57	-34.37
EBITDA, 1 Yr. Growth %	-17.97	0.53	-8.46	-14.01	-99.1
EBITA, 1 Yr. Growth %	-27.21	-21.05	-44	-75.71	-1.12T
EBIT, 1 Yr. Growth %	-32.22	-22.55	-48.18	-95.19	-7.97T
Earnings From Cont. Operations, 1 Yr. Growth %	-83.21	3.33T	-181.51	-52.23	133.67
Net Income, 1 Yr. Growth %	-83.58	3.33T	-181.51	-52.23	133.67
Normalized Net Income, 1 Yr. Growth %	-59.85	-11.3	-49.29	-272.55	300.45
Diluted EPS Before Extra, 1 Yr. Growth %	-84	3.14T	-176.77	-52.29	134.03
Accounts Receivable, 1 Yr. Growth %	5.72	52.57	31.94	-39.01	31.57
Inventory, 1 Yr. Growth %	26.38	89.86	15.63	3.57	0.75
Net Property, Plant and Equip., 1 Yr. Growth %	41.06	43.67	34.17	24.05	2.15
Total Assets, 1 Yr. Growth %	23.88	52.85	0.99	-0.21	-15.09
Tangible Book Value, 1 Yr. Growth %	265.32	187.37	-18.43	-6.72	-22.39
Common Equity, 1 Yr. Growth %	51.53	90.17	-13.83	-5.67	-14.95
Cash From Operations, 1 Yr. Growth %	5.93	173.33	66.16	-82.3	-50
Capital Expenditures, 1 Yr. Growth %	216.3	20.06	52.47	17.63	-44.93
Levered Free Cash Flow, 1 Yr. Growth %	-156.17	-126.24	-3.19T	-52.99	23.08
Unlevered Free Cash Flow, 1 Yr. Growth %	-134.95	-180.35	-1.43T	-55.46	25.83
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.51	17.66	22.48	12.44	2.98
Gross Profit, 2 Yr. CAGR %	5.95	6.79	17.66	7.48	-18.76
EBITDA, 2 Yr. CAGR %	-3.1	-9.41	-5.66	-10.17	-92.09
EBITA, 2 Yr. CAGR %	-8.56	-24.58	-35.05	-62.08	87.05
EBIT, 2 Yr. CAGR %	-10.89	-27.57	-37.39	-84.01	94.55
Earnings From Cont. Operations, 2 Yr. CAGR %	-72.73	140.33	428.96	-37.6	5.65
Net Income, 2 Yr. CAGR %	-72.75	137.66	428.96	-37.6	5.65
Normalized Net Income, 2 Yr. CAGR %	-30.74	-42.09	-34.41	-1.16	162.87
Diluted EPS Before Extra, 2 Yr. CAGR %	-73.27	127.6	398.56	-39.48	5.66
Accounts Receivable, 2 Yr. CAGR %	28.42	27	41.88	-10.29	-10.42
Inventory, 2 Yr. CAGR %	54.92	54.91	48.17	9.44	2.15
Net Property, Plant and Equip., 2 Yr. CAGR %	93.88	42.69	38.84	29.01	12.57
Total Assets, 2 Yr. CAGR %	37.67	37.58	24.24	0.39	-7.95
Tangible Book Value, 2 Yr. CAGR %	118.1	225.38	53.11	-12.77	-14.92
Common Equity, 2 Yr. CAGR %	30.57	69.94	28.01	-9.84	-10.43
Cash From Operations, 2 Yr. CAGR %	-46.5	70.16	113.11	-45.4	-70.25
Capital Expenditures, 2 Yr. CAGR %	88.55	94.87	35.3	33.92	-19.52
Levered Free Cash Flow, 2 Yr. CAGR %	-56.45	-61.18	190.69	278.73	-21.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	-63.58	-46.32	237.18	142.19	-25.14
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.84	18.08	18.95	15.98	8.85
Gross Profit, 3 Yr. CAGR %	15.41	10.6	9.41	11.66	-8.82
EBITDA, 3 Yr. CAGR %	16.32	-1.7	-9.09	-7.77	-80.61
EBITA, 3 Yr. CAGR %	13.92	-13.09	-31.7	-52.33	13.76
EBIT, 3 Yr. CAGR %	11.72	-15.16	-35.22	-73.16	26.24
Earnings From Cont. Operations, 3 Yr. CAGR %	-35.42	36.87	67.6	137.32	-3.1
Net Income, 3 Yr. CAGR %	-35.66	36.8	66.35	137.32	-3.1
Normalized Net Income, 3 Yr. CAGR %	2.36	-26.48	-44.6	-6.07	57.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-37	32.24	58.43	128.03	-5.01
Accounts Receivable, 3 Yr. CAGR %	21.01	36.01	28.63	7.08	1.92
Inventory, 3 Yr. CAGR %	34.62	65.79	40.52	31.5	6.46
Net Property, Plant and Equip., 3 Yr. CAGR %	64.93	75.72	39.79	33.72	19.35
Total Assets, 3 Yr. CAGR %	29.96	42.53	24.1	15.49	-5.06
Tangible Book Value, 3 Yr. CAGR %	144.25	139.78	105.17	29.79	-16.1
Common Equity, 3 Yr. CAGR %	29.75	48.11	35.52	15.63	-11.57
Cash From Operations, 3 Yr. CAGR %	60.44	-7.86	68.82	-6.6	-46.98
Capital Expenditures, 3 Yr. CAGR %	79.16	62.21	79.57	29.13	-0.42
Levered Free Cash Flow, 3 Yr. CAGR %	41.98	-63.07	66.97	57.72	160.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	21.92	-52.31	56.67	70.96	94.7
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	31.44	30.31	23.29	15.79	12.29
Gross Profit, 5 Yr. CAGR %	29.05	20.95	16.3	9.34	-2.87
EBITDA, 5 Yr. CAGR %	64.27	20.48	7.82	-5.18	-64.08
EBITA, 5 Yr. CAGR %	109.01	14.35	-8.26	-37.63	-3.49
EBIT, 5 Yr. CAGR %	73.58	10.02	-11.09	-56.48	1.09
Earnings From Cont. Operations, 5 Yr. CAGR %	-17.66	51.68	49.89	-0.03	39.35
Net Income, 5 Yr. CAGR %	-17.66	50.91	49.56	-0.06	38.73
Normalized Net Income, 5 Yr. CAGR %	64.24	-3.03	-14.74	-17.24	5.58
Diluted EPS Before Extra, 5 Yr. CAGR %	-19.73	45.3	44.1	-3.27	34.73
Accounts Receivable, 5 Yr. CAGR %	36.68	40.21	28.96	15.15	11.3
Inventory, 5 Yr. CAGR %	34.1	43.06	39.89	40.41	23.69
Net Property, Plant and Equip., 5 Yr. CAGR %	54.48	62.46	54.1	55.29	28.19
Total Assets, 5 Yr. CAGR %	38.36	44.56	27.63	23.89	10.12
Tangible Book Value, 5 Yr. CAGR %	26.83	63.27	102.97	60.01	44.28
Common Equity, 5 Yr. CAGR %	31.26	45.26	29.11	21.44	14.83
Cash From Operations, 5 Yr. CAGR %	23.37	12.66	79.74	-25.26	-15.47
Capital Expenditures, 5 Yr. CAGR %	54.81	64.6	60.12	50.24	30.26
Levered Free Cash Flow, 5 Yr. CAGR %	-8.24	-24.77	88.01	-6.29	21.61
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.93	-12.81	81.64	-8.65	16.29